The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
InventVacc Biologicals Inc
Vancouver, Canada
A
11-50 Employees
2016
Key takeaway
InventVacc is a global vaccine producer that focuses on high-quality and innovative products to combat infectious diseases. They leverage advanced vaccine technology and manufacturing processes, offering diverse services that support the development and commercialization of biologics.
Reference
Service
Breakthrough Vaccines that Change Patients' Lives
High-quality, cost-effective and sustainable global vaccine producer. The next generation of vaccines enabling you to live healthy.
Cambra Consulting Inc
Woodbridge, United States
B
1-10 Employees
2018
Key takeaway
The company has over 30 years of experience in quality assurance and manufacturing within the biopharmaceutical industry, specifically supporting vaccine manufacturers in achieving and maintaining WHO prequalification status.
Reference
Core business
Vacine Development & Manufacturing
Established since 2007
Virtuvax
Odijk, Netherlands
A
1-10 Employees
2016
Key takeaway
Virtuvax is a full-service vaccine consultancy with over 20 years of expertise, offering strategic advice and technology for vaccine development. They provide off-the-shelf technology for influenza vaccines and mucosal delivery, facilitating the transition from development to market.
Reference
Core business
Vaccines | Virtuvax
Virtuvax accelerates development of vaccines and biologics from preclinical until marketing. Virtuvax consults on preclinical, clinical, CMC and life cycle management of vaccines and provides technology.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Fluart Innovative Vaccines
Pilisborosjenő, Hungary
B
51-100 Employees
1991
Key takeaway
Fluart Kft. has over 25 years of experience in human vaccine production, specializing in the development of influenza vaccines that meet stringent efficacy standards. With a strong focus on research and development, Fluart is actively involved in innovative vaccine projects and adheres to high manufacturing practices, ensuring the quality and safety of its products.
Reference
Service
Vaccine manufacturers – Fluart Kft.
Cambridge Technologies
Worthington, United States
B
101-250 Employees
2015
Key takeaway
The company specializes in vaccine manufacturing, creating USDA-approved bacterial and viral products. They utilize Precision Vaccinology® and have an experienced team that customizes vaccines to meet individual needs, addressing emerging health challenges in swine and bovine.
Reference
Service
Vaccine Manufacturing: Creating USDA-approved bacterial & viral products
Our experienced team adapts commercial vaccine technologies to create USDA-approved bacterial & viral products. We customize products to each customer’s individual needs, including the potential for antigen concentration, multiple adjuvant choices, & the option of SoliDose implants in bovine products.
Vaccine Valley
6th of October, Egypt
D
251-500 Employees
2006
Key takeaway
Vaccine Valley is a specialized facility for producing various types of veterinary vaccines, having been the first in Egypt to receive a certificate of good manufacturing practices from the Egyptian Drug Authority. This demonstrates their commitment to high-quality vaccine manufacturing.
Reference
Product
Our Products – Vaccine Valley
Serum Institute of India Pvt. Ltd.
Pune, India
D
1001-5000 Employees
1996
Key takeaway
Serum Institute of India is a major vaccine supplier, providing vaccines to over 140 countries and ensuring that approximately 65% of the world's children receive at least one of their vaccines. The company's mission is to develop high-quality vaccines and offer them at affordable prices, contributing to the improvement of global health.
Reference
Core business
Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer
Pharmapan
Möhlin, Switzerland
A
11-50 Employees
-
Key takeaway
Pharmapan, a member of the Business Board, has expertise in sterile production and ODT fill-finish processes, which are crucial for vaccine manufacturing. Additionally, their team includes former executives from Novartis and Roche, enhancing their capability in the pharmaceutical sector.
Reference
Product
Vaccine delivery | Pharmapan
Cellvax
Maisons-Alfort, France
A
1-10 Employees
2001
Key takeaway
Cellvax is a preclinical CRO that specializes in innovative drug validation studies, which can be crucial for accelerating the development of vaccines addressing severe diseases. With a focus on enhancing the discovery process of candidate compounds, Cellvax's expertise may be relevant for vaccine research and development.
Reference
Core business
Company - Cellvax
Scandinavian Biopharma
Solna kommun, Sweden
A
11-50 Employees
2010
Key takeaway
The company is developing the first vaccine for protection against diarrhoea caused by ETEC, targeting vulnerable populations, particularly children under five in Low- and Middle-Income Countries. Their research-driven approach and significant funding from key partners underscore their commitment to vaccine innovation and global health improvement.
Reference
Product
Vaccines – Scandinavian Biopharma
Technologies which have been searched by others and may be interesting for you:
Vaccine manufacturing involves the complex process of producing vaccines that help prevent infectious diseases. This process typically includes several stages such as the development of the vaccine strain, cultivation of the microorganisms, and purification of the viral or bacterial components. Advanced techniques like recombinant DNA technology and cell culture are often utilized to ensure the safety and efficacy of the final product. In addition to biological production, vaccine manufacturing encompasses formulation and packaging, ensuring that the vaccines remain stable and effective during storage and distribution. Stringent regulatory standards are applied throughout the manufacturing process to guarantee that vaccines meet safety and efficacy requirements before they are administered to the public.
1. Research and Development
This initial phase involves extensive research to identify potential vaccine candidates. Scientists study pathogens to understand their biology, which aids in designing effective vaccines. Preclinical trials are conducted to assess safety and efficacy before advancing to human trials.
2. Clinical Trials
Once a vaccine candidate shows promise, it undergoes several phases of clinical trials. These trials involve testing the vaccine on human volunteers to evaluate its safety, immunogenicity, and effectiveness. Regulatory authorities monitor these trials closely.
3. Manufacturing Process
After successful trials, the vaccine enters mass production. This involves scaling up the production process, which requires specialized facilities. Key steps include culturing the pathogen, inactivating or attenuating it, and formulating the vaccine. Quality control measures are crucial at this stage to ensure safety and efficacy.
4. Quality Assurance
Before distribution, the vaccine undergoes rigorous quality assurance checks. This includes testing for sterility, potency, and stability. Compliance with regulatory standards is essential to ensure that the vaccine is safe for public use.
5. Distribution
Once approved, the vaccine is distributed to healthcare facilities. Cold chain logistics are often required to maintain the vaccine's effectiveness during transportation. Proper distribution ensures that the vaccine reaches the target population efficiently.
Vaccine manufacturing adheres to stringent protocols to ensure both safety and efficacy. This process begins with rigorous preclinical testing, where candidates are evaluated for their immune response and potential side effects. Once a vaccine candidate shows promise, it undergoes a series of clinical trials, which include multiple phases to assess its safety profile and effectiveness in diverse populations. Regulatory agencies, such as the FDA, require comprehensive data from these trials before granting approval. Throughout manufacturing, quality control measures are implemented to monitor the production environment, raw materials, and final products. These measures include standard operating procedures (SOPs) and Good Manufacturing Practices (GMPs), which help mitigate risks and ensure that each batch meets the established safety and efficacy standards.
Vaccine manufacturing employs a variety of advanced technologies to ensure safety, efficacy, and scalability. Cell culture technology is commonly used, allowing for the growth of viral particles in controlled environments, which are essential for many vaccines. This method can produce large quantities of vaccine antigens. Another critical technology is recombinant DNA technology, which involves inserting specific genes from pathogens into host cells to produce antigens. This approach is crucial for creating vaccines that are both effective and safe. Additionally, adjuvant formulation is utilized to enhance the immune response, improving the overall efficacy of the vaccine. These technologies combine to create robust vaccine manufacturing processes that meet global health needs.
Vaccine manufacturing faces several challenges that can impact production efficiency and product quality. One significant hurdle is the complex and time-consuming process of developing and scaling up manufacturing protocols. This often requires extensive research and testing to ensure that vaccines are both safe and effective. Furthermore, strict regulatory requirements add another layer of complexity, as manufacturers must comply with various standards set by health authorities. These regulations can vary by region and often necessitate rigorous documentation and quality control measures. Additionally, supply chain disruptions can affect the availability of raw materials and components, leading to delays in production and increased costs. Overall, navigating these challenges is crucial for successful vaccine development and distribution.
Some interesting numbers and facts about your company results for Vaccine Manufacturing
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 7214 |
| Amount of suitable service providers | 5644 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1991 |
| Youngest suiting company | 2018 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Vaccine Manufacturing
What are related technologies to Vaccine Manufacturing?
Based on our calculations related technologies to Vaccine Manufacturing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Vaccine Manufacturing?
The most represented industries which are working in Vaccine Manufacturing are Biotechnology, Pharmaceuticals, Other, Medical, Healthcare
How does ensun find these Vaccine Manufacturing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
